Trial
NCT02648633
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Virginia
Collaborators
—
Condition
Glioblastoma
Intervention
Stereotactic Radiosurgery
Why stopped
The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study was terminated early.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-31